Resumo

CUEVAS-GARCIA, Carlos; CALDERON-VALLEJO, Alejandra  e  BERRON-RUIZ, Laura. The neurology of COVID-19. Rev. alerg. Méx. [online]. 2020, vol.67, n.4, pp.338-349.  Epub 02-Jun-2021. ISSN 2448-9190.  https://doi.org/10.29262/ram.v67i4.828.

The clinical manifestations of COVID-19 are reminiscent of those of acute respiratory distress syndrome induced by cytokine release syndrome and secondary hemophagocytic lymphohistiocytosis that is observed in patients with other coronaviruses such as SARS-CoV and MERS-CoV. Neurologists face the challenge of assessing patients with pre-existing neurological diseases who have contracted SARS-CoV-2, patients with COVID-19 who present neurological emergencies, and patients who are carriers of the virus and have developed secondary neurological complications, either during the course of the disease or after it. Some authors and recent literature reports suggest that the presence of neurological manifestations in patients who are carriers of SARS-CoV-2 may be associated with a greater severity of the disease.

Palavras-chave : COVID-19; SARS-CoV-2; Acute respiratory distress syndrome; Cytokine storm; Neurological disorders.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )